Restatement of Previously Issued Financial Statements—

June 28, 2018,

the Company concluded that it did

not

meet all of the criteria for bill and hold treatment under Staff Accounting Bulletin Topic

for the Green Giant contract. In particular, the Company determined that performance obligations were

not

complete at the time title transferred to the customer as the unlabeled products under this contract were

not

ready for shipment. The Company has determined that the audited consolidated financial statements as of and for the years ended

March 31, 2016

and

2017

and the unaudited condensed consolidated financial statements as of and for each of the interim periods within the years ended

March 31, 2017

and

2018

should be restated to correct these inadvertent errors in the application of generally accepted accounting principles dealing with complex and technical accounting issues relating to “bill and hold” revenue recognition. For more information, see footnote

of the Company’s

March 31, 2018

-K filed on

June 29, 2018.

The Consolidated Statements of Cash Flows for the

three

and

nine

month periods ended

December 30, 2017

and

December

31,

2016

are

not

presented in the following tables because there is

impact on total cash flows from operating activities, investing activities and financing activities. The impact from the restatements within the operating activities section of the cash flow statement is illustrated in the balance sheet and income statement corrections presented below.

The following tables present a summary of the effects of these restatements:

	Consolidated Statements of Earnings (Loss)
	Three Months Ended
	December 30, 2017 (Unaudited)								December 31, 2016 (Unaudited)
	As						As		As					As
	Reported			Correction			Restated		Reported		Correction			Restated
Net Sales	$	392,714		$	(5,025	)	$	387,689	$	369,705	$	(12,938	)	$	356,767
Cost of Products Sold		361,013			(3,825	)		357,188		332,230		(13,389	)		318,841
Gross Profit		31,701			(1,200	)		30,501		37,475		451			37,926
Operating Income/(Loss)		11,471			(1,200	)		10,271		13,890		451			14,341
Earnings/(Loss) Before Income Taxes		7,459			(1,200	)		6,259		11,809		451			12,260
Income Tax (Benefit) Expense		(268	)		2,150			1,882		3,628		843			4,471
Net Earnings (Loss)		7,727			(3,350	)		4,377		8,181		(392	)		7,789
Earnings Per Common Share-Basic	$	0.79		$	(0.34	)	$	0.45	$	0.83	$	(0.04	)	$	0.79
Earnings Per Common Share-Diluted	$	0.78		$	(0.34	)	$	0.44	$	0.82	$	(0.04	)	$	0.78

	Nine Months Ended
	December 30, 2017 (Unaudited)									December 31, 2016 (Unaudited)
	As						As			As					As
	Reported			Correction			Restated			Reported		Correction			Restated
Net Sales	$	1,049,209		$	(34,123	)	$	1,015,086		$	979,566	$	1,942		$	981,508
Cost of Products Sold		981,344			(29,705	)		951,639			891,904		(1,302	)		890,602
Gross Profit		67,865			(4,418	)		63,447			87,662		3,244			90,906
Operating Income/(Loss)		13,893			(4,418	)		9,475			26,689		3,244			29,933
Earnings/(Loss) Before Income Taxes		3,252			(4,418	)		(1,166	)		20,480		3,244			23,724
Income Tax (Benefit) Expense		(2,524	)		919			(1,605	)		6,217		1,932			8,149
Net Earnings (Loss)		5,776			(5,337	)		439			14,263		1,312			15,575
Earnings Per Common Share-Basic	$	0.59		$	(0.55	)	$	0.04		$	1.44	$	0.14		$	1.58
Earnings Per Common Share-Diluted	$	0.58		$	(0.54	)	$	0.04		$	1.43	$	0.14		$	1.57

	Consolidated Balance Sheets
	As of December 30, 2017 (Unaudited)							As of March 31, 2017 (Audited)
	As					As		As					As
	Reported		Correction			Restated		Reported		Correction			Restated
Assets
Inventory	$	710,118	$	60,584		$	770,702	$	598,056	$	30,879		$	628,935
Total Current Assets		794,510		60,584			855,094		688,270		30,879			719,149
Total Assets		1,072,003		62,234			1,134,237		946,019		32,249			978,268

Liabilities and Stockholders' Equity
Deferred Revenue	$	545	$	79,606		$	80,151	$	545	$	45,555		$	46,100
Total Current Liabilities		162,423		79,610			242,033		132,277		45,487			177,764
Total Liabilities		635,204		76,628			711,832		511,758		41,306			553,064
Stockholders' Equity		436,799		(14,394	)		422,405		434,261		(9,057	)		425,204
Total Liabilities and Stockholders' Equity		1,072,003		62,234			1,134,237		946,019		32,249			978,268

	As of December 31, 2016 (Unaudited)
	As					As
	Reported		Correction			Restated
Assets
Inventory	$	656,368	$	43,077		$	699,445
Total Current Assets		750,156		43,077			793,233
Total Assets		1,004,711		49,035			1,053,746

Liabilities and Stockholders' Equity
Deferred Revenue	$	473	$	60,080		$	60,553
Total Current Liabilities		178,732		60,039			238,771
Total Liabilities		587,097		60,039			647,136
Stockholders' Equity		417,614		(11,004	)		406,610
Total Liabilities and Stockholders' Equity		1,004,711		49,035			1,053,746